0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GABA (CAS 56-12-2) Market Insights and Forecast to 2027
Published Date: June 2021
|
Report Code: QYRE-Auto-5188
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global GABA CAS 56 12 2 Market Insights and Forecast to 2027

Global GABA (CAS 56-12-2) Market Insights and Forecast to 2027

Code: QYRE-Auto-5188
Report
June 2021
149 Pages
QYResearch
Region: Global, China,
Description
Table of Content
Tables & Figures
GABA (CAS 56-12-2) market is segmented by Production Process, and by Application. Players, stakeholders, and other participants in the global GABA (CAS 56-12-2) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Production Process and by Application for the period 2016-2027.

Segment by Production Process

Biological Fermentation
Chemical Synthesis

Segment by Application

Pharmaceuticals & Food
Animal Feeds
Plants Growth Promoter
Others

BY COMPANY

Pharma Foods International
Kyowa Hakko
Sekisui Chemical
Zhejiang YiWan Biolabs
Shanghai Richen
Guangdong Luckerkong Biotech
Tianjin Shijitianlong Biotech
Ningxiang Jiayuan Biology Technology
Zhejiang Tianrui Chemical
Taizhou Xinyou Pharmaceutical & Chemical
Bloomage Biotechnology Corporation Limited
Bornsun Bioengineering
Luoyang Huarong
Anhui Xinnuobei
Hefei Maikeluo Biological Engineering
Hangzhou Viablife Biotech
Guangxi Hanhe Biotech

Production by Region

Japan
China

Consumption by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 GABA (CAS 56-12-2) Product Introduction
1.2 Market by Production Process
1.2.1 Global GABA (CAS 56-12-2) Market Size Growth Rate by Production Process
1.2.2 Biological Fermentation
1.2.3 Chemical Synthesis
1.3 Market by Application
1.3.1 Global GABA (CAS 56-12-2) Market Size Growth Rate by Application
1.3.2 Pharmaceuticals & Food
1.3.3 Animal Feeds
1.3.4 Plants Growth Promoter
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global GABA (CAS 56-12-2) Production
2.1 Global GABA (CAS 56-12-2) Production Capacity (2016-2027)
2.2 Global GABA (CAS 56-12-2) Production by Region: 2016 VS 2021 VS 2027
2.3 Global GABA (CAS 56-12-2) Production by Region
2.3.1 Global GABA (CAS 56-12-2) Historic Production by Region (2016-2021)
2.3.2 Global GABA (CAS 56-12-2) Forecasted Production by Region (2022-2027)
2.4 Japan
2.5 China
3 Global GABA (CAS 56-12-2) Sales in Volume & Value Estimates and Forecasts
3.1 Global GABA (CAS 56-12-2) Sales Estimates and Forecasts 2016-2027
3.2 Global GABA (CAS 56-12-2) Revenue Estimates and Forecasts 2016-2027
3.3 Global GABA (CAS 56-12-2) Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top GABA (CAS 56-12-2) Regions by Sales
3.4.1 Global Top GABA (CAS 56-12-2) Regions by Sales (2016-2021)
3.4.2 Global Top GABA (CAS 56-12-2) Regions by Sales (2022-2027)
3.5 Global Top GABA (CAS 56-12-2) Regions by Revenue
3.5.1 Global Top GABA (CAS 56-12-2) Regions by Revenue (2016-2021)
3.5.2 Global Top GABA (CAS 56-12-2) Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global GABA (CAS 56-12-2) Supply by Manufacturers
4.1.1 Global Top GABA (CAS 56-12-2) Manufacturers by Production Capacity (2020 VS 2021)
4.1.2 Global Top GABA (CAS 56-12-2) Manufacturers by Production (2016-2021)
4.2 Global GABA (CAS 56-12-2) Sales by Manufacturers
4.2.1 Global Top GABA (CAS 56-12-2) Manufacturers by Sales (2016-2021)
4.2.2 Global Top GABA (CAS 56-12-2) Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by GABA (CAS 56-12-2) Sales in 2020
4.3 Global GABA (CAS 56-12-2) Revenue by Manufacturers
4.3.1 Global Top GABA (CAS 56-12-2) Manufacturers by Revenue (2016-2021)
4.3.2 Global Top GABA (CAS 56-12-2) Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by GABA (CAS 56-12-2) Revenue in 2020
4.4 Global GABA (CAS 56-12-2) Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global GABA (CAS 56-12-2) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global GABA (CAS 56-12-2) Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global GABA (CAS 56-12-2) Sales by Production Process
5.1.1 Global GABA (CAS 56-12-2) Historical Sales by Production Process (2016-2021)
5.1.2 Global GABA (CAS 56-12-2) Forecasted Sales by Production Process (2022-2027)
5.1.3 Global GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027)
5.2 Global GABA (CAS 56-12-2) Revenue by Production Process
5.2.1 Global GABA (CAS 56-12-2) Historical Revenue by Production Process (2016-2021)
5.2.2 Global GABA (CAS 56-12-2) Forecasted Revenue by Production Process (2022-2027)
5.2.3 Global GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027)
5.3 Global GABA (CAS 56-12-2) Price by Production Process
5.3.1 Global GABA (CAS 56-12-2) Price by Production Process (2016-2021)
5.3.2 Global GABA (CAS 56-12-2) Price Forecast by Production Process (2022-2027)
6 Market Size by Application
6.1 Global GABA (CAS 56-12-2) Sales by Application
6.1.1 Global GABA (CAS 56-12-2) Historical Sales by Application (2016-2021)
6.1.2 Global GABA (CAS 56-12-2) Forecasted Sales by Application (2022-2027)
6.1.3 Global GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027)
6.2 Global GABA (CAS 56-12-2) Revenue by Application
6.2.1 Global GABA (CAS 56-12-2) Historical Revenue by Application (2016-2021)
6.2.2 Global GABA (CAS 56-12-2) Forecasted Revenue by Application (2022-2027)
6.2.3 Global GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027)
6.3 Global GABA (CAS 56-12-2) Price by Application
6.3.1 Global GABA (CAS 56-12-2) Price by Application (2016-2021)
6.3.2 Global GABA (CAS 56-12-2) Price Forecast by Application (2022-2027)
7 North America
7.1 North America GABA (CAS 56-12-2) Market Size by Production Process
7.1.1 North America GABA (CAS 56-12-2) Sales by Production Process (2016-2027)
7.1.2 North America GABA (CAS 56-12-2) Revenue by Production Process (2016-2027)
7.2 North America GABA (CAS 56-12-2) Market Size by Application
7.2.1 North America GABA (CAS 56-12-2) Sales by Application (2016-2027)
7.2.2 North America GABA (CAS 56-12-2) Revenue by Application (2016-2027)
7.3 North America GABA (CAS 56-12-2) Sales by Country
7.3.1 North America GABA (CAS 56-12-2) Sales by Country (2016-2027)
7.3.2 North America GABA (CAS 56-12-2) Revenue by Country (2016-2027)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe GABA (CAS 56-12-2) Market Size by Production Process
8.1.1 Europe GABA (CAS 56-12-2) Sales by Production Process (2016-2027)
8.1.2 Europe GABA (CAS 56-12-2) Revenue by Production Process (2016-2027)
8.2 Europe GABA (CAS 56-12-2) Market Size by Application
8.2.1 Europe GABA (CAS 56-12-2) Sales by Application (2016-2027)
8.2.2 Europe GABA (CAS 56-12-2) Revenue by Application (2016-2027)
8.3 Europe GABA (CAS 56-12-2) Sales by Country
8.3.1 Europe GABA (CAS 56-12-2) Sales by Country (2016-2027)
8.3.2 Europe GABA (CAS 56-12-2) Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific GABA (CAS 56-12-2) Market Size by Production Process
9.1.1 Asia Pacific GABA (CAS 56-12-2) Sales by Production Process (2016-2027)
9.1.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Production Process (2016-2027)
9.2 Asia Pacific GABA (CAS 56-12-2) Market Size by Application
9.2.1 Asia Pacific GABA (CAS 56-12-2) Sales by Application (2016-2027)
9.2.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Application (2016-2027)
9.3 Asia Pacific GABA (CAS 56-12-2) Sales by Region
9.3.1 Asia Pacific GABA (CAS 56-12-2) Sales by Region (2016-2027)
9.3.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America GABA (CAS 56-12-2) Market Size by Production Process
10.1.1 Latin America GABA (CAS 56-12-2) Sales by Production Process (2016-2027)
10.1.2 Latin America GABA (CAS 56-12-2) Revenue by Production Process (2016-2027)
10.2 Latin America GABA (CAS 56-12-2) Market Size by Application
10.2.1 Latin America GABA (CAS 56-12-2) Sales by Application (2016-2027)
10.2.2 Latin America GABA (CAS 56-12-2) Revenue by Application (2016-2027)
10.3 Latin America GABA (CAS 56-12-2) Sales by Country
10.3.1 Latin America GABA (CAS 56-12-2) Sales by Country (2016-2027)
10.3.2 Latin America GABA (CAS 56-12-2) Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa GABA (CAS 56-12-2) Market Size by Production Process
11.1.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Production Process (2016-2027)
11.1.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Production Process (2016-2027)
11.2 Middle East and Africa GABA (CAS 56-12-2) Market Size by Application
11.2.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Application (2016-2027)
11.2.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Application (2016-2027)
11.3 Middle East and Africa GABA (CAS 56-12-2) Sales by Country
11.3.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Country (2016-2027)
11.3.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Pharma Foods International
12.1.1 Pharma Foods International Corporation Information
12.1.2 Pharma Foods International Overview
12.1.3 Pharma Foods International GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Pharma Foods International GABA (CAS 56-12-2) Product Description
12.1.5 Pharma Foods International Related Developments
12.2 Kyowa Hakko
12.2.1 Kyowa Hakko Corporation Information
12.2.2 Kyowa Hakko Overview
12.2.3 Kyowa Hakko GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 Kyowa Hakko GABA (CAS 56-12-2) Product Description
12.2.5 Kyowa Hakko Related Developments
12.3 Sekisui Chemical
12.3.1 Sekisui Chemical Corporation Information
12.3.2 Sekisui Chemical Overview
12.3.3 Sekisui Chemical GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 Sekisui Chemical GABA (CAS 56-12-2) Product Description
12.3.5 Sekisui Chemical Related Developments
12.4 Zhejiang YiWan Biolabs
12.4.1 Zhejiang YiWan Biolabs Corporation Information
12.4.2 Zhejiang YiWan Biolabs Overview
12.4.3 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.4.4 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Product Description
12.4.5 Zhejiang YiWan Biolabs Related Developments
12.5 Shanghai Richen
12.5.1 Shanghai Richen Corporation Information
12.5.2 Shanghai Richen Overview
12.5.3 Shanghai Richen GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.5.4 Shanghai Richen GABA (CAS 56-12-2) Product Description
12.5.5 Shanghai Richen Related Developments
12.6 Guangdong Luckerkong Biotech
12.6.1 Guangdong Luckerkong Biotech Corporation Information
12.6.2 Guangdong Luckerkong Biotech Overview
12.6.3 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.6.4 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Product Description
12.6.5 Guangdong Luckerkong Biotech Related Developments
12.7 Tianjin Shijitianlong Biotech
12.7.1 Tianjin Shijitianlong Biotech Corporation Information
12.7.2 Tianjin Shijitianlong Biotech Overview
12.7.3 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.7.4 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Product Description
12.7.5 Tianjin Shijitianlong Biotech Related Developments
12.8 Ningxiang Jiayuan Biology Technology
12.8.1 Ningxiang Jiayuan Biology Technology Corporation Information
12.8.2 Ningxiang Jiayuan Biology Technology Overview
12.8.3 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.8.4 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Product Description
12.8.5 Ningxiang Jiayuan Biology Technology Related Developments
12.9 Zhejiang Tianrui Chemical
12.9.1 Zhejiang Tianrui Chemical Corporation Information
12.9.2 Zhejiang Tianrui Chemical Overview
12.9.3 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.9.4 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Product Description
12.9.5 Zhejiang Tianrui Chemical Related Developments
12.10 Taizhou Xinyou Pharmaceutical & Chemical
12.10.1 Taizhou Xinyou Pharmaceutical & Chemical Corporation Information
12.10.2 Taizhou Xinyou Pharmaceutical & Chemical Overview
12.10.3 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.10.4 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Product Description
12.10.5 Taizhou Xinyou Pharmaceutical & Chemical Related Developments
12.11 Bloomage Biotechnology Corporation Limited
12.11.1 Bloomage Biotechnology Corporation Limited Corporation Information
12.11.2 Bloomage Biotechnology Corporation Limited Overview
12.11.3 Bloomage Biotechnology Corporation Limited GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.11.4 Bloomage Biotechnology Corporation Limited GABA (CAS 56-12-2) Product Description
12.11.5 Bloomage Biotechnology Corporation Limited Related Developments
12.12 Bornsun Bioengineering
12.12.1 Bornsun Bioengineering Corporation Information
12.12.2 Bornsun Bioengineering Overview
12.12.3 Bornsun Bioengineering GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.12.4 Bornsun Bioengineering GABA (CAS 56-12-2) Product Description
12.12.5 Bornsun Bioengineering Related Developments
12.13 Luoyang Huarong
12.13.1 Luoyang Huarong Corporation Information
12.13.2 Luoyang Huarong Overview
12.13.3 Luoyang Huarong GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.13.4 Luoyang Huarong GABA (CAS 56-12-2) Product Description
12.13.5 Luoyang Huarong Related Developments
12.14 Anhui Xinnuobei
12.14.1 Anhui Xinnuobei Corporation Information
12.14.2 Anhui Xinnuobei Overview
12.14.3 Anhui Xinnuobei GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.14.4 Anhui Xinnuobei GABA (CAS 56-12-2) Product Description
12.14.5 Anhui Xinnuobei Related Developments
12.15 Hefei Maikeluo Biological Engineering
12.15.1 Hefei Maikeluo Biological Engineering Corporation Information
12.15.2 Hefei Maikeluo Biological Engineering Overview
12.15.3 Hefei Maikeluo Biological Engineering GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.15.4 Hefei Maikeluo Biological Engineering GABA (CAS 56-12-2) Product Description
12.15.5 Hefei Maikeluo Biological Engineering Related Developments
12.16 Hangzhou Viablife Biotech
12.16.1 Hangzhou Viablife Biotech Corporation Information
12.16.2 Hangzhou Viablife Biotech Overview
12.16.3 Hangzhou Viablife Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.16.4 Hangzhou Viablife Biotech GABA (CAS 56-12-2) Product Description
12.16.5 Hangzhou Viablife Biotech Related Developments
12.17 Guangxi Hanhe Biotech
12.17.1 Guangxi Hanhe Biotech Corporation Information
12.17.2 Guangxi Hanhe Biotech Overview
12.17.3 Guangxi Hanhe Biotech GABA (CAS 56-12-2) Sales, Price, Revenue and Gross Margin (2016-2021)
12.17.4 Guangxi Hanhe Biotech GABA (CAS 56-12-2) Product Description
12.17.5 Guangxi Hanhe Biotech Related Developments
13 Industry Chain and Sales Channels Analysis
13.1 GABA (CAS 56-12-2) Industry Chain Analysis
13.2 GABA (CAS 56-12-2) Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 GABA (CAS 56-12-2) Production Mode & Process
13.4 GABA (CAS 56-12-2) Sales and Marketing
13.4.1 GABA (CAS 56-12-2) Sales Channels
13.4.2 GABA (CAS 56-12-2) Distributors
13.5 GABA (CAS 56-12-2) Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 GABA (CAS 56-12-2) Industry Trends
14.2 GABA (CAS 56-12-2) Market Drivers
14.3 GABA (CAS 56-12-2) Market Challenges
14.4 GABA (CAS 56-12-2) Market Restraints
15 Key Finding in The Global GABA (CAS 56-12-2) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
    Table 1. Global GABA (CAS 56-12-2) Market Size Growth Rate by Production Process, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Biological Fermentation
    Table 3. Major Manufacturers of Chemical Synthesis
    Table 4. Global GABA (CAS 56-12-2) Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
    Table 5. Global GABA (CAS 56-12-2) Production by Region: 2016 VS 2021 VS 2027 (MT)
    Table 6. Global GABA (CAS 56-12-2) Production by Region (2016-2021) & (MT)
    Table 7. Global GABA (CAS 56-12-2) Production Market Share by Region (2016-2021)
    Table 8. Global GABA (CAS 56-12-2) Production by Region (2022-2027) & (MT)
    Table 9. Global GABA (CAS 56-12-2) Production Market Share by Region (2022-2027)
    Table 10. Global GABA (CAS 56-12-2) Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 11. Global GABA (CAS 56-12-2) Sales by Region (2016-2021) & (MT)
    Table 12. Global GABA (CAS 56-12-2) Sales Market Share by Region (2016-2021)
    Table 13. Global GABA (CAS 56-12-2) Sales by Region (2022-2027) & (MT)
    Table 14. Global GABA (CAS 56-12-2) Sales Market Share by Region (2022-2027)
    Table 15. Global GABA (CAS 56-12-2) Revenue by Region (2016-2021) & (US$ Million)
    Table 16. Global GABA (CAS 56-12-2) Revenue Market Share by Region (2016-2021)
    Table 17. Global GABA (CAS 56-12-2) Revenue by Region (2022-2027) & (US$ Million)
    Table 18. Global GABA (CAS 56-12-2) Revenue Market Share by Region (2022-2027)
    Table 19. Global GABA (CAS 56-12-2) Production Capacity by Manufacturers (2016-2021) & (MT)
    Table 20. Global GABA (CAS 56-12-2) Capacity Market Share by Manufacturers (2016-2021)
    Table 21. Global GABA (CAS 56-12-2) Production by Manufacturers (2016-2021) & (MT)
    Table 22. Global GABA (CAS 56-12-2) Production Market Share by Manufacturers (2016-2021)
    Table 23. Global GABA (CAS 56-12-2) Sales by Manufacturers (2016-2021) & (MT)
    Table 24. Global GABA (CAS 56-12-2) Sales Share by Manufacturers (2016-2021)
    Table 25. Global GABA (CAS 56-12-2) Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 26. Global GABA (CAS 56-12-2) Revenue Share by Manufacturers (2016-2021)
    Table 27. GABA (CAS 56-12-2) Price by Manufacturers 2016-2021 (USD/MT)
    Table 28. Global GABA (CAS 56-12-2) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 29. Global GABA (CAS 56-12-2) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GABA (CAS 56-12-2) as of 2020)
    Table 30. GABA (CAS 56-12-2) Manufacturing Base Distribution and Headquarters
    Table 31. Manufacturers GABA (CAS 56-12-2) Product Offered
    Table 32. Date of Manufacturers Enter into GABA (CAS 56-12-2) Market
    Table 33. Mergers & Acquisitions, Expansion Plans
    Table 34. Global GABA (CAS 56-12-2) Sales by Production Process (2016-2021) & (MT)
    Table 35. Global GABA (CAS 56-12-2) Sales by Production Process (2022-2027) & (MT)
    Table 36. Global GABA (CAS 56-12-2) Sales Share by Production Process (2016-2021)
    Table 37. Global GABA (CAS 56-12-2) Sales Share by Production Process (2022-2027)
    Table 38. Global GABA (CAS 56-12-2) Revenue by Production Process (2016-2021) & (US$ Million)
    Table 39. Global GABA (CAS 56-12-2) Revenue by Production Process (2022-2027) & (US$ Million)
    Table 40. Global GABA (CAS 56-12-2) Revenue Share by Production Process (2016-2021)
    Table 41. Global GABA (CAS 56-12-2) Revenue Share by Production Process (2022-2027)
    Table 42. GABA (CAS 56-12-2) Price by Production Process (2016-2021) & (USD/MT)
    Table 43. Global GABA (CAS 56-12-2) Price Forecast by Production Process (2022-2027) & (USD/MT)
    Table 44. Global GABA (CAS 56-12-2) Sales by Application (2016-2021) & (MT)
    Table 45. Global GABA (CAS 56-12-2) Sales by Application (2022-2027) & (MT)
    Table 46. Global GABA (CAS 56-12-2) Sales Share by Application (2016-2021)
    Table 47. Global GABA (CAS 56-12-2) Sales Share by Application (2022-2027)
    Table 48. Global GABA (CAS 56-12-2) Revenue by Application (2016-2021) & (US$ Million)
    Table 49. Global GABA (CAS 56-12-2) Revenue by Application (2022-2027) & (US$ Million)
    Table 50. Global GABA (CAS 56-12-2) Revenue Share by Application (2016-2021)
    Table 51. Global GABA (CAS 56-12-2) Revenue Share by Application (2022-2027)
    Table 52. GABA (CAS 56-12-2) Price by Application (2016-2021) & (USD/MT)
    Table 53. Global GABA (CAS 56-12-2) Price Forecast by Application (2022-2027) & (USD/MT)
    Table 54. North America GABA (CAS 56-12-2) Sales by Production Process (2016-2021) & (MT)
    Table 55. North America GABA (CAS 56-12-2) Sales by Production Process (2022-2027) & (MT)
    Table 56. North America GABA (CAS 56-12-2) Revenue by Production Process (2016-2021) & (US$ Million)
    Table 57. North America GABA (CAS 56-12-2) Revenue by Production Process (2022-2027) & (US$ Million)
    Table 58. North America GABA (CAS 56-12-2) Sales by Application (2016-2021) & (MT)
    Table 59. North America GABA (CAS 56-12-2) Sales by Application (2022-2027) & (MT)
    Table 60. North America GABA (CAS 56-12-2) Revenue by Application (2016-2021) & (US$ Million)
    Table 61. North America GABA (CAS 56-12-2) Revenue by Application (2022-2027) & (US$ Million)
    Table 62. North America GABA (CAS 56-12-2) Sales by Country (2016-2021) & (MT)
    Table 63. North America GABA (CAS 56-12-2) Sales by Country (2022-2027) & (MT)
    Table 64. North America GABA (CAS 56-12-2) Revenue by Country (2016-2021) & (US$ Million)
    Table 65. North America GABA (CAS 56-12-2) Revenue by Country (2022-2027) & (US$ Million)
    Table 66. Europe GABA (CAS 56-12-2) Sales by Production Process (2016-2021) & (MT)
    Table 67. Europe GABA (CAS 56-12-2) Sales by Production Process (2022-2027) & (MT)
    Table 68. Europe GABA (CAS 56-12-2) Revenue by Production Process (2016-2021) & (US$ Million)
    Table 69. Europe GABA (CAS 56-12-2) Revenue by Production Process (2022-2027) & (US$ Million)
    Table 70. Europe GABA (CAS 56-12-2) Sales by Application (2016-2021) & (MT)
    Table 71. Europe GABA (CAS 56-12-2) Sales by Application (2022-2027) & (MT)
    Table 72. Europe GABA (CAS 56-12-2) Revenue by Application (2016-2021) & (US$ Million)
    Table 73. Europe GABA (CAS 56-12-2) Revenue by Application (2022-2027) & (US$ Million)
    Table 74. Europe GABA (CAS 56-12-2) Sales by Country (2016-2021) & (MT)
    Table 75. Europe GABA (CAS 56-12-2) Sales by Country (2022-2027) & (MT)
    Table 76. Europe GABA (CAS 56-12-2) Revenue by Country (2016-2021) & (US$ Million)
    Table 77. Europe GABA (CAS 56-12-2) Revenue by Country (2022-2027) & (US$ Million)
    Table 78. Asia Pacific GABA (CAS 56-12-2) Sales by Production Process (2016-2021) & (MT)
    Table 79. Asia Pacific GABA (CAS 56-12-2) Sales by Production Process (2022-2027) & (MT)
    Table 80. Asia Pacific GABA (CAS 56-12-2) Revenue by Production Process (2016-2021) & (US$ Million)
    Table 81. Asia Pacific GABA (CAS 56-12-2) Revenue by Production Process (2022-2027) & (US$ Million)
    Table 82. Asia Pacific GABA (CAS 56-12-2) Sales by Application (2016-2021) & (MT)
    Table 83. Asia Pacific GABA (CAS 56-12-2) Sales by Application (2022-2027) & (MT)
    Table 84. Asia Pacific GABA (CAS 56-12-2) Revenue by Application (2016-2021) & (US$ Million)
    Table 85. Asia Pacific GABA (CAS 56-12-2) Revenue by Application (2022-2027) & (US$ Million)
    Table 86. Asia Pacific GABA (CAS 56-12-2) Sales by Region (2016-2021) & (MT)
    Table 87. Asia Pacific GABA (CAS 56-12-2) Sales by Region (2022-2027) & (MT)
    Table 88. Asia Pacific GABA (CAS 56-12-2) Revenue by Region (2016-2021) & (US$ Million)
    Table 89. Asia Pacific GABA (CAS 56-12-2) Revenue by Region (2022-2027) & (US$ Million)
    Table 90. Latin America GABA (CAS 56-12-2) Sales by Production Process (2016-2021) & (MT)
    Table 91. Latin America GABA (CAS 56-12-2) Sales by Production Process (2022-2027) & (MT)
    Table 92. Latin America GABA (CAS 56-12-2) Revenue by Production Process (2016-2021) & (US$ Million)
    Table 93. Latin America GABA (CAS 56-12-2) Revenue by Production Process (2022-2027) & (US$ Million)
    Table 94. Latin America GABA (CAS 56-12-2) Sales by Application (2016-2021) & (MT)
    Table 95. Latin America GABA (CAS 56-12-2) Sales by Application (2022-2027) & (MT)
    Table 96. Latin America GABA (CAS 56-12-2) Revenue by Application (2016-2021) & (US$ Million)
    Table 97. Latin America GABA (CAS 56-12-2) Revenue by Application (2022-2027) & (US$ Million)
    Table 98. Latin America GABA (CAS 56-12-2) Sales by Country (2016-2021) & (MT)
    Table 99. Latin America GABA (CAS 56-12-2) Sales by Country (2022-2027) & (MT)
    Table 100. Latin America GABA (CAS 56-12-2) Revenue by Country (2016-2021) & (US$ Million)
    Table 101. Latin America GABA (CAS 56-12-2) Revenue by Country (2022-2027) & (US$ Million)
    Table 102. Middle East and Africa GABA (CAS 56-12-2) Sales by Production Process (2016-2021) & (MT)
    Table 103. Middle East and Africa GABA (CAS 56-12-2) Sales by Production Process (2022-2027) & (MT)
    Table 104. Middle East and Africa GABA (CAS 56-12-2) Revenue by Production Process (2016-2021) & (US$ Million)
    Table 105. Middle East and Africa GABA (CAS 56-12-2) Revenue by Production Process (2022-2027) & (US$ Million)
    Table 106. Middle East and Africa GABA (CAS 56-12-2) Sales by Application (2016-2021) & (MT)
    Table 107. Middle East and Africa GABA (CAS 56-12-2) Sales by Application (2022-2027) & (MT)
    Table 108. Middle East and Africa GABA (CAS 56-12-2) Revenue by Application (2016-2021) & (US$ Million)
    Table 109. Middle East and Africa GABA (CAS 56-12-2) Revenue by Application (2022-2027) & (US$ Million)
    Table 110. Middle East and Africa GABA (CAS 56-12-2) Sales by Country (2016-2021) & (MT)
    Table 111. Middle East and Africa GABA (CAS 56-12-2) Sales by Country (2022-2027) & (MT)
    Table 112. Middle East and Africa GABA (CAS 56-12-2) Revenue by Country (2016-2021) & (US$ Million)
    Table 113. Middle East and Africa GABA (CAS 56-12-2) Revenue by Country (2022-2027) & (US$ Million)
    Table 114. Pharma Foods International Corporation Information
    Table 115. Pharma Foods International Description and Major Businesses
    Table 116. Pharma Foods International GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 117. Pharma Foods International GABA (CAS 56-12-2) Product
    Table 118. Pharma Foods International Recent Development
    Table 119. Kyowa Hakko Corporation Information
    Table 120. Kyowa Hakko Description and Major Businesses
    Table 121. Kyowa Hakko GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 122. Kyowa Hakko GABA (CAS 56-12-2) Product
    Table 123. Kyowa Hakko Recent Development
    Table 124. Sekisui Chemical Corporation Information
    Table 125. Sekisui Chemical Description and Major Businesses
    Table 126. Sekisui Chemical GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 127. Sekisui Chemical GABA (CAS 56-12-2) Product
    Table 128. Sekisui Chemical Recent Development
    Table 129. Zhejiang YiWan Biolabs Corporation Information
    Table 130. Zhejiang YiWan Biolabs Description and Major Businesses
    Table 131. Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 132. Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Product
    Table 133. Zhejiang YiWan Biolabs Recent Development
    Table 134. Shanghai Richen Corporation Information
    Table 135. Shanghai Richen Description and Major Businesses
    Table 136. Shanghai Richen GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 137. Shanghai Richen GABA (CAS 56-12-2) Product
    Table 138. Shanghai Richen Recent Development
    Table 139. Guangdong Luckerkong Biotech Corporation Information
    Table 140. Guangdong Luckerkong Biotech Description and Major Businesses
    Table 141. Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 142. Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Product
    Table 143. Guangdong Luckerkong Biotech Recent Development
    Table 144. Tianjin Shijitianlong Biotech Corporation Information
    Table 145. Tianjin Shijitianlong Biotech Description and Major Businesses
    Table 146. Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 147. Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Product
    Table 148. Tianjin Shijitianlong Biotech Recent Development
    Table 149. Ningxiang Jiayuan Biology Technology Corporation Information
    Table 150. Ningxiang Jiayuan Biology Technology Description and Major Businesses
    Table 151. Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 152. Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Product
    Table 153. Ningxiang Jiayuan Biology Technology Recent Development
    Table 154. Zhejiang Tianrui Chemical Corporation Information
    Table 155. Zhejiang Tianrui Chemical Description and Major Businesses
    Table 156. Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 157. Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Product
    Table 158. Zhejiang Tianrui Chemical Recent Development
    Table 159. Taizhou Xinyou Pharmaceutical & Chemical Corporation Information
    Table 160. Taizhou Xinyou Pharmaceutical & Chemical Description and Major Businesses
    Table 161. Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 162. Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Product
    Table 163. Taizhou Xinyou Pharmaceutical & Chemical Recent Development
    Table 164. Bloomage Biotechnology Corporation Limited Corporation Information
    Table 165. Bloomage Biotechnology Corporation Limited Description and Major Businesses
    Table 166. Bloomage Biotechnology Corporation Limited GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 167. Bloomage Biotechnology Corporation Limited GABA (CAS 56-12-2) Product
    Table 168. Bloomage Biotechnology Corporation Limited Recent Development
    Table 169. Bornsun Bioengineering Corporation Information
    Table 170. Bornsun Bioengineering Description and Major Businesses
    Table 171. Bornsun Bioengineering GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 172. Bornsun Bioengineering GABA (CAS 56-12-2) Product
    Table 173. Bornsun Bioengineering Recent Development
    Table 174. Luoyang Huarong Corporation Information
    Table 175. Luoyang Huarong Description and Major Businesses
    Table 176. Luoyang Huarong GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 177. Luoyang Huarong GABA (CAS 56-12-2) Product
    Table 178. Luoyang Huarong Recent Development
    Table 179. Anhui Xinnuobei Corporation Information
    Table 180. Anhui Xinnuobei Description and Major Businesses
    Table 181. Anhui Xinnuobei GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 182. Anhui Xinnuobei GABA (CAS 56-12-2) Product
    Table 183. Anhui Xinnuobei Recent Development
    Table 184. Hefei Maikeluo Biological Engineering Corporation Information
    Table 185. Hefei Maikeluo Biological Engineering Description and Major Businesses
    Table 186. Hefei Maikeluo Biological Engineering GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 187. Hefei Maikeluo Biological Engineering GABA (CAS 56-12-2) Product
    Table 188. Hefei Maikeluo Biological Engineering Recent Development
    Table 189. Hangzhou Viablife Biotech Corporation Information
    Table 190. Hangzhou Viablife Biotech Description and Major Businesses
    Table 191. Hangzhou Viablife Biotech GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 192. Hangzhou Viablife Biotech GABA (CAS 56-12-2) Product
    Table 193. Hangzhou Viablife Biotech Recent Development
    Table 194. Guangxi Hanhe Biotech Corporation Information
    Table 195. Guangxi Hanhe Biotech Description and Major Businesses
    Table 196. Guangxi Hanhe Biotech GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 197. Guangxi Hanhe Biotech GABA (CAS 56-12-2) Product
    Table 198. Guangxi Hanhe Biotech Recent Development
    Table 199. Key Raw Materials Lists
    Table 200. Raw Materials Key Suppliers Lists
    Table 201. GABA (CAS 56-12-2) Distributors List
    Table 202. GABA (CAS 56-12-2) Customers List
    Table 203. GABA (CAS 56-12-2) Market Trends
    Table 204. GABA (CAS 56-12-2) Market Drivers
    Table 205. GABA (CAS 56-12-2) Market Challenges
    Table 206. GABA (CAS 56-12-2) Market Restraints
    Table 207. Research Programs/Design for This Report
    Table 208. Key Data Information from Secondary Sources
    Table 209. Key Data Information from Primary Sources
List of Figures
    Figure 1. GABA (CAS 56-12-2) Product Picture
    Figure 2. Global GABA (CAS 56-12-2) Market Share by Production Process in 2020 & 2027
    Figure 3. Biological Fermentation Product Picture
    Figure 4. Chemical Synthesis Product Picture
    Figure 5. Global GABA (CAS 56-12-2) Market Share by Application in 2020 & 2027
    Figure 6. Pharmaceuticals & Food
    Figure 7. Animal Feeds
    Figure 8. Plants Growth Promoter
    Figure 9. Others
    Figure 10. GABA (CAS 56-12-2) Report Years Considered
    Figure 11. Global GABA (CAS 56-12-2) Capacity, Production and Utilization (2016-2027) & (MT)
    Figure 12. Global GABA (CAS 56-12-2) Production Market Share by Region in Percentage: 2020 Versus 2027
    Figure 13. Global GABA (CAS 56-12-2) Production Market Share by Region (2016-2021)
    Figure 14. Global GABA (CAS 56-12-2) Production Market Share by Region (2022-2027)
    Figure 15. GABA (CAS 56-12-2) Production Growth Rate in Japan (2016-2027) & (MT)
    Figure 16. GABA (CAS 56-12-2) Production Growth Rate in China (2016-2027) & (MT)
    Figure 17. Global GABA (CAS 56-12-2) Sales 2016-2027 (MT)
    Figure 18. Global GABA (CAS 56-12-2) Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 19. Global GABA (CAS 56-12-2) Revenue 2016-2027 (US$ Million)
    Figure 20. Global GABA (CAS 56-12-2) Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 21. Global GABA (CAS 56-12-2) Sales Market Share by Region (2016-2021)
    Figure 22. Global GABA (CAS 56-12-2) Sales Market Share by Region (2022-2027)
    Figure 23. North America GABA (CAS 56-12-2) Sales YoY (2016-2027) & (MT)
    Figure 24. North America GABA (CAS 56-12-2) Revenue YoY (2016-2027) & (US$ Million)
    Figure 25. Europe GABA (CAS 56-12-2) Sales YoY (2016-2027) & (MT)
    Figure 26. Europe GABA (CAS 56-12-2) Revenue YoY (2016-2027) & (US$ Million)
    Figure 27. Asia-Pacific GABA (CAS 56-12-2) Sales YoY (2016-2027) & (MT)
    Figure 28. Asia-Pacific GABA (CAS 56-12-2) Revenue YoY (2016-2027) & (US$ Million)
    Figure 29. Latin America GABA (CAS 56-12-2) Sales YoY (2016-2027) & (MT)
    Figure 30. Latin America GABA (CAS 56-12-2) Revenue YoY (2016-2027) & (US$ Million)
    Figure 31. Middle East & Africa GABA (CAS 56-12-2) Sales YoY (2016-2027) & (MT)
    Figure 32. Middle East & Africa GABA (CAS 56-12-2) Revenue YoY (2016-2027) & (US$ Million)
    Figure 33. The Top 10 and Top 5 Players Market Share by GABA (CAS 56-12-2) Sales in 2020
    Figure 34. The Top 10 and Top 5 Players Market Share by GABA (CAS 56-12-2) Revenue in 2020
    Figure 35. GABA (CAS 56-12-2) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 36. Global GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027)
    Figure 37. Global GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027)
    Figure 38. Global GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027)
    Figure 39. Global GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027)
    Figure 40. North America GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027)
    Figure 41. North America GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027)
    Figure 42. North America GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027)
    Figure 43. North America GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027)
    Figure 44. North America GABA (CAS 56-12-2) Sales Share by Country (2016-2027)
    Figure 45. North America GABA (CAS 56-12-2) Revenue Share by Country (2016-2027)
    Figure 46. U.S. GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 47. Canada GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 48. Europe GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027)
    Figure 49. Europe GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027)
    Figure 50. Europe GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027)
    Figure 51. Europe GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027)
    Figure 52. Europe GABA (CAS 56-12-2) Sales Share by Country (2016-2027)
    Figure 53. Europe GABA (CAS 56-12-2) Revenue Share by Country (2016-2027)
    Figure 54. Germany GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 55. France GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 56. U.K. GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 57. Italy GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 58. Russia GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 59. Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027)
    Figure 60. Asia Pacific GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027)
    Figure 61. Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027)
    Figure 62. Asia Pacific GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027)
    Figure 63. Asia Pacific GABA (CAS 56-12-2) Sales Share by Region (2016-2027)
    Figure 64. Asia Pacific GABA (CAS 56-12-2) Revenue Share by Region (2016-2027)
    Figure 65. China GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 66. Japan GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 67. South Korea GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 68. India GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 69. Australia GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 70. Taiwan GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 71. Indonesia GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 72. Thailand GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 73. Malaysia GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 74. Philippines GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 75. Latin America GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027)
    Figure 76. Latin America GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027)
    Figure 77. Latin America GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027)
    Figure 78. Latin America GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027)
    Figure 79. Latin America GABA (CAS 56-12-2) Sales Share by Country (2016-2027)
    Figure 80. Latin America GABA (CAS 56-12-2) Revenue Share by Country (2016-2027)
    Figure 81. Mexico GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 82. Brazil GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 83. Argentina GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 84. Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027)
    Figure 85. Middle East and Africa GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027)
    Figure 86. Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027)
    Figure 87. Middle East and Africa GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027)
    Figure 88. Middle East and Africa GABA (CAS 56-12-2) Sales Share by Country (2016-2027)
    Figure 89. Middle East and Africa GABA (CAS 56-12-2) Revenue Share by Country (2016-2027)
    Figure 90. Turkey GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 91. Saudi Arabia GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 92. U.A.E GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million)
    Figure 93. GABA (CAS 56-12-2) Value Chain
    Figure 94. GABA (CAS 56-12-2) Production Process
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Bottom-up and Top-down Approaches for This Report
    Figure 98. Data Triangulation
    Figure 99. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global Cytotoxicity Assay Market Size Status and Forecast 2021 2027
Global Cytotoxicity Assay Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-39V907
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Aquaculture Vaccine Market Size Status and Forecast 2021 2027
Global Aquaculture Vaccine Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-3I3192
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Intranasal Corticosteroids Market Size Status and Forecast 2021 2027
Global Intranasal Corticosteroids Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-25X2634
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Tumor Tracking System Market Size Status and Forecast 2021 2027
Global Tumor Tracking System Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-21F2812
Sun Jul 18 00:00:00 UTC 2021

Add to Cart